EDTUTC-4 New YorkLog in Sign up

NAMSW
NewAmsterdam Pharma Company N.V. Warrant
stockNASDAQWarrant

At CloseOct 16, 2026 10:37:43 AM EDT

8.82USD-41.744%(-6.32)1,932

NAMSW News

Day breaks

04:01 PM EDTNewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.

08:00 AM EDTNewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease ·

GlobeNewswire Inc.

09:00 AM EDTNewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) ·

GlobeNewswire Inc.